Biomedical Research Organization Launches Thought-Provoking New Billboard Campaign WASHINGTON, April 5, 2011 /PRNewswire-USNewswire/ -- The Foundation for Biomedical Research (FBR) announced today it has launched a new, targeted out-of-home advertising campaign in five cities, as part of its national ResearchSaves(TM) campaign.

LEXINGTON, Ky., April 22 /PRNewswire/ -- Transposagen Biopharmaceuticals, Inc., based in Lexington, KY, has announced today that it has added 170 genetically modified rats and related biomaterials to its database of laboratory rats with a genetic modification that can mimic a human disease.

LEXINGTON, Ky., Jan.

LEXINGTON, Ky., Aug. 6 /PRNewswire/ -- Transposagen Biopharmaceuticals, Inc. based in Lexington, KY announced today that its scientists and collaborators from the Medical College of Wisconsin have created and characterized the world's first rat model of severe combined immunodeficiency, or SCID.

U.S.